FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2664341209> ?p ?o ?g. }

• W2664341209 endingPage "104" @default.
• W2664341209 startingPage "97" @default.
• W2664341209 abstract "Background: Upgrading following prostate biopsy is very common in clinical practice. This study investigated whether the use of 5-alpha reductase inhibitors (ARI) and alpha blockers affect known clinical predictors of Gleason score upgrading or not. Materials and Methods: A retrospective study on 998 patients treated with robotic assisted laparoscopic prostatectomy for clinically localized biopsy Gleason score 6 prostate cancer were studied. The logarithm of prostate specific antigen concentration, prostate size and tumor volume were compared on the basis of the medication history of 5-ARIs and alpha blockers in the cohort of biopsy Gleason 6 patients with benign prostatic hyperplasia history, and patients whose prostate sizes fall in the top quartile. We compared known clinical and pathologic characteristics associated with upgrading in regression models with and without the addition of medications. Results: Alpha blockers, but not 5-ARI were associated with a bigger prostate. Upgrading was associated with older age (OR 1.03, 95% CI 1.01-1.06), higher BMI (OR 1.00 CI 1.01-1.08), higher log prostate specific antigen (OR 7.32, CI 3.546-15.52), smaller prostate size (OR 0.97, CI 0.96-0.98), fewer biopsy cores (OR 0.96 CI 0.92-0.99), more positive cores (OR 1.20, CI 1.08-1.34), and higher percentage of tumor at biopsy (OR 1.02, CI 1.01-1.03). Neither of the two medication classes were a significant predictor of upgrading. Medications made minimal changes in the multivariate predictive models. Conclusion: Although, alpha blockers were associate with bigger prostate size, the modulating effects of alpha blockers and 5-ARIs on common predictors of Gleason score upgrading was not significant." @default.
• W2664341209 created "2017-06-30" @default.
• W2664341209 creator A5012218293 @default.
• W2664341209 creator A5045841123 @default.
• W2664341209 creator A5053721306 @default.
• W2664341209 creator A5054971545 @default.
• W2664341209 creator A5061662589 @default.
• W2664341209 creator A5078274522 @default.
• W2664341209 creator A5088397980 @default.
• W2664341209 date "2017-07-01" @default.
• W2664341209 modified "2023-10-17" @default.
• W2664341209 title "The Modulating Effects of Benign Prostate Enlargement Medications on Upgrading Predictors in Patients with Gleason 6 at Biopsy" @default.
• W2664341209 cites W1502134003 @default.
• W2664341209 cites W1640337403 @default.
• W2664341209 cites W1909851795 @default.
• W2664341209 cites W1976862087 @default.
• W2664341209 cites W1978761040 @default.
• W2664341209 cites W1994016727 @default.
• W2664341209 cites W2003836327 @default.
• W2664341209 cites W2007281445 @default.
• W2664341209 cites W2007791257 @default.
• W2664341209 cites W2028933689 @default.
• W2664341209 cites W2029877777 @default.
• W2664341209 cites W2042589569 @default.
• W2664341209 cites W2056030667 @default.
• W2664341209 cites W2078797104 @default.
• W2664341209 cites W2083043726 @default.
• W2664341209 cites W2095151261 @default.
• W2664341209 cites W2105250521 @default.
• W2664341209 cites W2109466343 @default.
• W2664341209 cites W2109929523 @default.
• W2664341209 cites W2110860120 @default.
• W2664341209 cites W2140444142 @default.
• W2664341209 cites W2142991244 @default.
• W2664341209 cites W2288294539 @default.
• W2664341209 cites W2294765885 @default.
• W2664341209 cites W2301685087 @default.
• W2664341209 cites W2340422569 @default.
• W2664341209 cites W2476646956 @default.
• W2664341209 cites W2516711802 @default.
• W2664341209 cites W2133929387 @default.
• W2664341209 doi "https://doi.org/10.1159/000447159" @default.
• W2664341209 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5527191" @default.
• W2664341209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28785195" @default.
• W2664341209 hasPublicationYear "2017" @default.
• W2664341209 type Work @default.
• W2664341209 sameAs 2664341209 @default.
• W2664341209 citedByCount "2" @default.
• W2664341209 countsByYear W26643412092021 @default.
• W2664341209 countsByYear W26643412092022 @default.
• W2664341209 crossrefType "journal-article" @default.
• W2664341209 hasAuthorship W2664341209A5012218293 @default.
• W2664341209 hasAuthorship W2664341209A5045841123 @default.
• W2664341209 hasAuthorship W2664341209A5053721306 @default.
• W2664341209 hasAuthorship W2664341209A5054971545 @default.
• W2664341209 hasAuthorship W2664341209A5061662589 @default.
• W2664341209 hasAuthorship W2664341209A5078274522 @default.
• W2664341209 hasAuthorship W2664341209A5088397980 @default.
• W2664341209 hasBestOaLocation W26643412091 @default.
• W2664341209 hasConcept C121608353 @default.
• W2664341209 hasConcept C126322002 @default.
• W2664341209 hasConcept C126894567 @default.
• W2664341209 hasConcept C167135981 @default.
• W2664341209 hasConcept C2775874879 @default.
• W2664341209 hasConcept C2775934546 @default.
• W2664341209 hasConcept C2776235491 @default.
• W2664341209 hasConcept C2777562237 @default.
• W2664341209 hasConcept C2778878792 @default.
• W2664341209 hasConcept C2779466945 @default.
• W2664341209 hasConcept C2780192828 @default.
• W2664341209 hasConcept C2781217009 @default.
• W2664341209 hasConcept C2781406297 @default.
• W2664341209 hasConcept C2910366748 @default.
• W2664341209 hasConcept C44249647 @default.
• W2664341209 hasConcept C68443243 @default.
• W2664341209 hasConcept C71924100 @default.
• W2664341209 hasConceptScore W2664341209C121608353 @default.
• W2664341209 hasConceptScore W2664341209C126322002 @default.
• W2664341209 hasConceptScore W2664341209C126894567 @default.
• W2664341209 hasConceptScore W2664341209C167135981 @default.
• W2664341209 hasConceptScore W2664341209C2775874879 @default.
• W2664341209 hasConceptScore W2664341209C2775934546 @default.
• W2664341209 hasConceptScore W2664341209C2776235491 @default.
• W2664341209 hasConceptScore W2664341209C2777562237 @default.
• W2664341209 hasConceptScore W2664341209C2778878792 @default.
• W2664341209 hasConceptScore W2664341209C2779466945 @default.
• W2664341209 hasConceptScore W2664341209C2780192828 @default.
• W2664341209 hasConceptScore W2664341209C2781217009 @default.
• W2664341209 hasConceptScore W2664341209C2781406297 @default.
• W2664341209 hasConceptScore W2664341209C2910366748 @default.
• W2664341209 hasConceptScore W2664341209C44249647 @default.
• W2664341209 hasConceptScore W2664341209C68443243 @default.
• W2664341209 hasConceptScore W2664341209C71924100 @default.
• W2664341209 hasIssue "2" @default.
• W2664341209 hasLocation W26643412091 @default.
• W2664341209 hasLocation W26643412092 @default.
• W2664341209 hasLocation W26643412093 @default.
• W2664341209 hasOpenAccess W2664341209 @default.

• next